Johnson & Johnson

• 

  POINT: Rising Dividends for Retirement Income

  By Charlie Farrell  |  October 1, 2011

  The topic of retirement income is on the top of most advisors’ minds these days.

• Do Credit Ratings Matter?

  By Ronald Delegge, ETFguide.com  |  September 29, 2011

  Over the past few years, credit rating agencies have done a lot to diminish their credibility. Not only did they contribute to the Great Meltdown by inaccurately rating debt, but they have allowed the role of credit ratings to become murkier. What do the ratings now mean for financial advisors...

• 

  10 Best Investments for a Default or Downgrade

  By John Sullivan, AdvisorOne  |  July 29, 2011

  Municipal investments are at risk of default, money markets have broken the buck and now the U.S. Government is at threat of a downgrade—where in the world can investors find safety?

• Morningstar Confab Puts Focus on TIPs, Munis, Commodities & Ratings

  By Kenneth Silber, Research  |  July 1, 2011

• What's Next for Health Care?

  By Staff Writer  |  May 1, 2010

  The health care sector has never seen anything like this and neither has the American public. After months of political wrangling, the Affordable Health Care for...

• Changing Shades of Blue

  By James J. Green, AdvisorOne  |  July 1, 2009

  As of December 31, 2008, the top five holdings in Massachusetts Investors Trust, which this year celebrates the 85th anniversary of its founding, were the...

• Will Health-Care ETFs Recover?

  By Staff Writer  |  March 1, 2009

  Despite their defensive nature, health-care stocks have been hospitalized, falling around 24 percent on average over the past year. The swift decline has created attractive...

• Quality Flight Gains Height

  By Staff Writer  |  July 1, 2007

  Dividends are back in vogue in a big way. Wall Street observers point to several factors contributing to this 180-degree shift -- Baby Boomers facing...

• Buying The Future

  By Staff Writer  |  December 1, 2005

  If you were to suggest to colleagues or clients that the biotechnology sector presents a good opportunity for investment, they might very well respond with...

• Interview: Tony Weber and Chuck McCurdy of ABN AMRO Veredus Select Growth Fund

  By Staff Writer  |  September 30, 2005

  S&P Rank: 5 Stars Using Inefficiency to Their Advantage